Amarin Corp. Plc (AMRN)
13.82
-0.27
(-1.92%)
USD |
NASDAQ |
Aug 24, 16:00
13.82
0.00 (0.00%)
After-Hours: 19:20
Amarin Price to Book Value : 0.6543 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 0.6671 |
| August 20, 2026 | 0.6656 |
| August 19, 2026 | 0.6808 |
| August 18, 2026 | 0.669 |
| August 17, 2026 | 0.6633 |
| August 14, 2026 | 0.6661 |
| August 13, 2026 | 0.6699 |
| August 12, 2026 | 0.6656 |
| August 11, 2026 | 0.6633 |
| August 10, 2026 | 0.668 |
| August 07, 2026 | 0.6798 |
| August 06, 2026 | 0.6751 |
| August 05, 2026 | 0.6822 |
| August 04, 2026 | 0.6817 |
| August 03, 2026 | 0.6694 |
| July 31, 2026 | 0.6751 |
| July 30, 2026 | 0.6737 |
| July 29, 2026 | 0.6704 |
| July 28, 2026 | 0.6604 |
| July 27, 2026 | 0.6538 |
| July 24, 2026 | 0.6415 |
| July 23, 2026 | 0.6439 |
| July 22, 2026 | 0.6491 |
| July 21, 2026 | 0.6595 |
| July 20, 2026 | 0.6439 |
| Date | Value |
|---|---|
| July 17, 2026 | 0.66 |
| July 16, 2026 | 0.6713 |
| July 15, 2026 | 0.6846 |
| July 14, 2026 | 0.6803 |
| July 13, 2026 | 0.6959 |
| July 10, 2026 | 0.7045 |
| July 09, 2026 | 0.7158 |
| July 08, 2026 | 0.7182 |
| July 07, 2026 | 0.7319 |
| July 06, 2026 | 0.7447 |
| July 02, 2026 | 0.775 |
| July 01, 2026 | 0.7797 |
| June 30, 2026 | 0.7547 |
| June 29, 2026 | 0.7432 |
| June 26, 2026 | 0.7427 |
| June 25, 2026 | 0.7633 |
| June 24, 2026 | 0.7661 |
| June 23, 2026 | 0.7455 |
| June 22, 2026 | 0.738 |
| June 18, 2026 | 0.7483 |
| June 17, 2026 | 0.7362 |
| June 16, 2026 | 0.7082 |
| June 15, 2026 | 0.7166 |
| June 12, 2026 | 0.7114 |
| June 11, 2026 | 0.6956 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Neurocrine Biosciences, Inc. | 4.210 |
| Cellectis SA | 7.871 |
| Alkermes Plc | 4.525 |
| Akari Therapeutics Plc | 0.7078 |
| Liquidia Corp. | 32.09 |
Price to Book Value Related Metrics
| PS Ratio | 1.550 |
| Price to Free Cash Flow | 18.52 |
| Price | 13.82 |
| Earnings Yield | -9.39% |
| Market Cap | 290.25M |